Della Via F, Alvarez M, Basting R, Olalla Saad S
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513933
PMC: 10385775.
DOI: 10.3390/ph16071021.
Gaobotse G, Venkataraman S, Brown P, Masisi K, Kwape T, Nkwe D
Front Pharmacol. 2023; 14:1122388.
PMID: 36865913
PMC: 9971233.
DOI: 10.3389/fphar.2023.1122388.
Farhan M, Rizvi A, Ali F, Ahmad A, Aatif M, Malik A
Front Oncol. 2022; 12:998346.
PMID: 36147917
PMC: 9487716.
DOI: 10.3389/fonc.2022.998346.
Kluska M, Wozniak K
Int J Mol Sci. 2021; 22(12).
PMID: 34202987
PMC: 8235666.
DOI: 10.3390/ijms22126602.
Khan S, Ullah M, Siddique R, Liu Y, Ullah I, Xue M
Front Oncol. 2019; 9:499.
PMID: 31263675
PMC: 6585473.
DOI: 10.3389/fonc.2019.00499.
ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals.
NavaneethaKrishnan S, Rosales J, Lee K
Oxid Med Cell Longev. 2019; 2019:9051542.
PMID: 31217841
PMC: 6536988.
DOI: 10.1155/2019/9051542.
New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.
Nunez M, Chana-Cuevas P
Pharmaceuticals (Basel). 2018; 11(4).
PMID: 30347635
PMC: 6316457.
DOI: 10.3390/ph11040109.
Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites.
Shin S, Moon S, Kim W, Paek S, Park H, Lee C
Int J Mol Sci. 2018; 19(9).
PMID: 30200668
PMC: 6163735.
DOI: 10.3390/ijms19092651.
Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.
Frenkel M, Sapire K
Curr Oncol Rep. 2017; 19(12):79.
PMID: 29032389
DOI: 10.1007/s11912-017-0635-0.
Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate.
Min K, Kwon T
Integr Med Res. 2017; 3(1):16-24.
PMID: 28664074
PMC: 5481703.
DOI: 10.1016/j.imr.2013.12.001.
(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
Zhang Y, Yang N, Zhou F, Shen T, Duan T, Zhou J
PLoS One. 2012; 7(10):e46749.
PMID: 23056433
PMC: 3466311.
DOI: 10.1371/journal.pone.0046749.
Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: A novel opportunity for diabetes treatment?.
Yu Z, Li D, Ling W, Jin T
World J Diabetes. 2012; 3(1):19-28.
PMID: 22253942
PMC: 3258535.
DOI: 10.4239/wjd.v3.i1.19.
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer.
Shamim U, Hanif S, Albanyan A, Beck F, Bao B, Wang Z
J Cell Physiol. 2011; 227(4):1493-500.
PMID: 21678400
PMC: 3185178.
DOI: 10.1002/jcp.22865.
The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention.
Forester S, Lambert J
Mol Nutr Food Res. 2011; 55(6):844-54.
PMID: 21538850
PMC: 3679539.
DOI: 10.1002/mnfr.201000641.
Caspase-independent apoptosis induction of quorum-sensing autoinducer analogs against chronic myeloid leukemia K562.
Hazawa M, Kudo M, Iwata T, Saito K, Takahashi K, Igarashi J
Invest New Drugs. 2011; 30(3):862-9.
PMID: 21207239
DOI: 10.1007/s10637-010-9623-z.
Protective effect of catechin on apoptosis of the lens epithelium in rats with N-methyl-N-nitrosourea-induced cataracts.
Lee S, Ko I, Kim S, Kim D, Kang B
Korean J Ophthalmol. 2010; 24(2):101-7.
PMID: 20379460
PMC: 2850997.
DOI: 10.3341/kjo.2010.24.2.101.
Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.
Nance C, Siwak E, Shearer W
J Allergy Clin Immunol. 2009; 123(2):459-65.
PMID: 19203663
PMC: 2665796.
DOI: 10.1016/j.jaci.2008.12.024.
Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement.
Bandele O, Clawson S, Osheroff N
Chem Res Toxicol. 2008; 21(6):1253-60.
PMID: 18461976
PMC: 2737509.
DOI: 10.1021/tx8000785.
Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells.
Yao K, Ye P, Zhang L, Tan J, Tang X, Zhang Y
Mol Vis. 2008; 14:217-23.
PMID: 18334937
PMC: 2266088.
(-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.
Bandele O, Osheroff N
Chem Res Toxicol. 2008; 21(4):936-43.
PMID: 18293940
PMC: 2893035.
DOI: 10.1021/tx700434v.